Okuda Takeshi, Fujita Mitsugu, Kato Amami
Department of Neurosurgery, Kindai University Faculty of Medicine, Osaka, Japan
Department of Microbiology, Kindai University Faculty of Medicine, Osaka, Japan.
Anticancer Res. 2019 Aug;39(8):4491-4494. doi: 10.21873/anticanres.13624.
BACKGROUND/AIM: High-mobility group box 1 (HMGB1) is a nuclear DNA-binding protein that exerts a range of proinflammatory actions when it is secreted extracellularly. We hypothesized that HMGB1 released from damaged cells in pituitary apoplexy would exacerbate the neurological symptoms due to acute inflammation.
All the patients included in this study suffered from non-functioning pituitary adenoma. Four patients with apoplexy and three patients without apoplexy were included in this study. They underwent endonasal transsphenoidal endoscopic surgery to resect the tumors. We conducted enzyme-linked immunosorbent assay (ELISA) to measure HMGB1 in the surgical specimens.
Patients with apoplexy expressed HMGB1 at significantly higher levels than those in the non-apoplexy group (p=0.0478).
HMGB1 may be involved in subacute inflammation of pituitary apoplexy. Further work is needed to elucidate the detailed biological significance of HMGB1 in this disease.
背景/目的:高迁移率族蛋白B1(HMGB1)是一种核DNA结合蛋白,当它分泌到细胞外时会产生一系列促炎作用。我们推测垂体卒中时受损细胞释放的HMGB1会因急性炎症而加重神经症状。
本研究纳入的所有患者均患有无功能性垂体腺瘤。本研究纳入了4例卒中患者和3例非卒中患者。他们接受了鼻内镜经蝶窦手术以切除肿瘤。我们进行了酶联免疫吸附测定(ELISA)以测量手术标本中的HMGB1。
卒中患者HMGB1的表达水平明显高于非卒中组(p = 0.0478)。
HMGB1可能参与垂体卒中的亚急性炎症。需要进一步开展工作以阐明HMGB1在该疾病中的详细生物学意义。